CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C18004 | BRD-K48812570 | macitentan | EDNRA; EDNRB | Endothelin receptor antagonist | -- | Details |
| C18005 | BRD-K48813201 | BRD-K48813201 | -- | -- | -- | Details |
| C18006 | BRD-K48816779 | BRD-K48816779 | -- | -- | -- | Details |
| C18007 | BRD-K48823327 | BRD-K48823327 | -- | -- | -- | Details |
| C18008 | BRD-K48826825 | S-26948 | -- | -- | -- | Details |
| C18009 | BRD-K48827674 | BRD-K48827674 | -- | -- | -- | Details |
| C18010 | BRD-K48830578 | OMDM-2 | -- | -- | -- | Details |
| C18011 | BRD-K48835133 | BRD-K48835133 | -- | -- | -- | Details |
| C18012 | BRD-K48835953 | BRD-K48835953 | -- | -- | -- | Details |
| C18013 | BRD-K48840041 | BRD-K48840041 | -- | -- | -- | Details |
| C18014 | BRD-K48844671 | BRD-K48844671 | -- | -- | -- | Details |
| C18015 | BRD-K48845054 | BRD-K48845054 | -- | -- | -- | Details |
| C18016 | BRD-K48849176 | BRD-K48849176 | -- | -- | -- | Details |
| C18017 | BRD-K48853221 | BRD-K48853221 | -- | -- | -- | Details |
| C18018 | BRD-K48853765 | BRD-K48853765 | -- | -- | -- | Details |
| C18019 | BRD-K48860322 | BRD-K48860322 | -- | -- | -- | Details |
| C18020 | BRD-K48860650 | BRD-K48860650 | -- | -- | -- | Details |
| C18021 | BRD-K48861177 | BRD-K48861177 | -- | -- | -- | Details |
| C18022 | BRD-K48863591 | BRD-K48863591 | -- | -- | -- | Details |
| C18023 | BRD-K48863671 | BRD-K48863671 | -- | -- | -- | Details |
| C18024 | BRD-K48864121 | BRD-K48864121 | -- | -- | -- | Details |
| C18025 | BRD-K48864953 | BRD-K48864953 | -- | -- | -- | Details |
| C18026 | BRD-K48869804 | icilin | TRPM8; TRPA1 | TRPV agonist | -- | Details |
| C18027 | BRD-K48875051 | ligustilide | -- | -- | -- | Details |
| C18028 | BRD-K48875630 | BRD-K48875630 | -- | -- | -- | Details |
| C18029 | BRD-K48877010 | BRD-K48877010 | -- | -- | -- | Details |
| C18030 | BRD-K48880196 | BRD-K48880196 | -- | -- | -- | Details |
| C18031 | BRD-K48892307 | sasapyrine | PTGS1 | NFKB pathway inhibitor | -- | Details |
| C18032 | BRD-K48894757 | laropiprant | PTGDR | Prostanoid receptor antagonist | -- | Details |
| C18033 | BRD-K48899005 | BRD-K48899005 | -- | -- | -- | Details |
| C18034 | BRD-K48900723 | BRD-K48900723 | -- | -- | -- | Details |
| C18035 | BRD-K48911375 | BRD-K48911375 | -- | -- | -- | Details |
| C18036 | BRD-K48912618 | BRD-K48912618 | -- | -- | -- | Details |
| C18037 | BRD-K48914099 | BRD-K48914099 | -- | -- | -- | Details |
| C18038 | BRD-K48918097 | BRD-K48918097 | -- | -- | -- | Details |
| C18039 | BRD-K48918933 | BRD-K48918933 | -- | -- | -- | Details |
| C18040 | BRD-K48920366 | O-PHENYLENEDIAMINE.2HCL | -- | -- | -- | Details |
| C18041 | BRD-K48922193 | BRD-K48922193 | -- | -- | -- | Details |
| C18042 | BRD-K48923155 | BRD-K48923155 | -- | -- | -- | Details |
| C18043 | BRD-K48923948 | BMS-641988 | AR | Androgen receptor antagonist | -- | Details |
| C18044 | BRD-K48924007 | BRD-K48924007 | -- | -- | -- | Details |
| C18045 | BRD-K48927563 | BRD-K48927563 | -- | -- | -- | Details |
| C18046 | BRD-K48930263 | BRD-K48930263 | -- | -- | -- | Details |
| C18047 | BRD-K48932581 | cetraxate | GAST | Mucus protecting agent | -- | Details |
| C18048 | BRD-K48935217 | epothilone | TUBB | Microtubule inhibitor | -- | Details |
| C18049 | BRD-K48945537 | SA-1455791 | -- | -- | -- | Details |
| C18050 | BRD-K48950795 | BRD-K48950795 | -- | -- | -- | Details |
| C18051 | BRD-K48954843 | BRD-K48954843 | -- | -- | -- | Details |
| C18052 | BRD-K48969316 | BRD-K48969316 | CASP1 | Caspase inhibitor | -- | Details |
| C18053 | BRD-K48970916 | danazol | ESR1; GNRHR | Estrogen receptor antagonist; Progesterone receptor agonist | -- | Details |
| C18054 | BRD-K48974000 | BRD-K48974000 | -- | -- | -- | Details |
| C18055 | BRD-K48986374 | BRD-K48986374 | -- | -- | -- | Details |
| C18056 | BRD-K48987279 | BRD-K48987279 | -- | -- | -- | Details |
| C18057 | BRD-K48994888 | BRD-K48994888 | -- | -- | -- | Details |
| C18058 | BRD-K48995011 | BRD-K48995011 | -- | -- | -- | Details |
| C18059 | BRD-K48999921 | BRD-K48999921 | -- | -- | -- | Details |
| C18060 | BRD-K49005570 | BRD-K49005570 | -- | -- | -- | Details |
| C18061 | BRD-K49005954 | BRD-K49005954 | -- | -- | -- | Details |
| C18062 | BRD-K49010888 | BRD-K49010888 | -- | -- | -- | Details |
| C18063 | BRD-K49014970 | BRD-K49014970 | -- | -- | -- | Details |
| C18064 | BRD-K49023266 | caprolactam | -- | -- | -- | Details |
| C18065 | BRD-K49027941 | PSB-1115 | ADORA1; ADORA2B | Adenosine receptor antagonist | -- | Details |
| C18066 | BRD-K49029187 | BRD-K49029187 | -- | -- | -- | Details |
| C18067 | BRD-K49031847 | BRD-K49031847 | -- | -- | -- | Details |
| C18068 | BRD-K49039223 | BRD-K49039223 | -- | -- | -- | Details |
| C18069 | BRD-K49040541 | BRD-K49040541 | -- | -- | -- | Details |
| C18070 | BRD-K49042040 | BRD-K49042040 | -- | -- | -- | Details |
| C18071 | BRD-K49047603 | BRD-K49047603 | -- | -- | -- | Details |
| C18072 | BRD-K49047615 | SA-1459975 | -- | -- | -- | Details |
| C18073 | BRD-K49049886 | CGS-15943 | ADORA1; ADORA2A; ADORA2B | Adenosine receptor antagonist | -- | Details |
| C18074 | BRD-K49050984 | BRD-K49050984 | -- | -- | -- | Details |
| C18075 | BRD-K49051633 | BRD-K49051633 | -- | -- | -- | Details |
| C18076 | BRD-K49055432 | A-66 | -- | -- | -- | Details |
| C18077 | BRD-K49060658 | anethole | -- | -- | -- | Details |
| C18078 | BRD-K49061529 | BRD-K49061529 | -- | -- | -- | Details |
| C18079 | BRD-K49066776 | BRD-K49066776 | -- | -- | -- | Details |
| C18080 | BRD-K49070267 | BRD-K49070267 | -- | -- | -- | Details |
| C18081 | BRD-K49071277 | securinine | GABRA1 | TP53 activator; GABA receptor antagonist | -- | Details |
| C18082 | BRD-K49071649 | BRD-K49071649 | -- | -- | -- | Details |
| C18083 | BRD-K49075727 | nintedanib | FGFR1; FGFR3; FLT1; FLT4; KDR; PDGFRA; PDGFRB | FGFR inhibitor; PDGFR inhibitor; VEGFR inhibitor | -- | Details |
| C18084 | BRD-K49076555 | etretinate | RARA; RXRG | Protein synthesis inhibitor | -- | Details |
| C18085 | BRD-K49076793 | BRD-K49076793 | -- | -- | -- | Details |
| C18086 | BRD-K49080168 | BRD-K49080168 | -- | -- | -- | Details |
| C18087 | BRD-K49090949 | BRD-K49090949 | -- | -- | -- | Details |
| C18088 | BRD-K49092745 | BRD-K49092745 | -- | -- | -- | Details |
| C18089 | BRD-K49093373 | BRD-K49093373 | -- | -- | -- | Details |
| C18090 | BRD-K49094605 | BRD-K49094605 | -- | -- | -- | Details |
| C18091 | BRD-K49094915 | BRD-K49094915 | -- | -- | -- | Details |
| C18092 | BRD-K49098390 | BRD-K49098390 | -- | -- | -- | Details |
| C18093 | BRD-K49103536 | BRD-K49103536 | -- | -- | -- | Details |
| C18094 | BRD-K49103797 | BRD-K49103797 | -- | -- | -- | Details |
| C18095 | BRD-K49108064 | BRD-K49108064 | -- | -- | -- | Details |
| C18096 | BRD-K49111258 | prazosin | ADRA1D; ADRA1B; ADRA1A; ADRA2A; ADRA2B; ADRA2C | Adrenergic receptor antagonist | -- | Details |
| C18097 | BRD-K49111930 | BRD-K49111930 | -- | -- | -- | Details |
| C18098 | BRD-K49114771 | BRD-K49114771 | -- | -- | -- | Details |
| C18099 | BRD-K49119234 | TMPH | -- | -- | tmph | Details |
| C18100 | BRD-K49123127 | BRD-K49123127 | -- | -- | -- | Details |
| C18101 | BRD-K49125116 | BRD-K49125116 | -- | -- | -- | Details |
| C18102 | BRD-K49126478 | BRD-K49126478 | -- | -- | -- | Details |
| C18103 | BRD-K49132774 | BRD-K49132774 | -- | -- | -- | Details |